The 5-choice continuous performance test: Evidence for a translational test of vigilance for mice

PLoS ONE

Volumn 4, Issue 1, 2009, Pages

  Young, Jared W ^a   Light, Gregory A ^a   Marston, Hugh M ^b   Sharp, Richard ^a   Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALERTNESS; ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CONSCIOUSNESS LEVEL; CONSTRUCT VALIDITY; CONTROLLED STUDY; DBA 2 MOUSE; MALE; MENTAL TASK; MOUSE; NONHUMAN; PERCEPTIVE DISCRIMINATION; REACTION TIME; SIGNAL DETECTION; STRAIN DIFFERENCE; TASK PERFORMANCE; ANIMAL; ANIMAL BEHAVIOR; ATTENTION; C57BL MOUSE; COGNITION; DBA MOUSE; LEARNING; METHODOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; REPRODUCIBILITY; SPECIES DIFFERENCE; STATISTICAL MODEL;

MUS; RODENTIA;

ANIMALS; ATTENTION; BEHAVIOR, ANIMAL; COGNITION; LEARNING; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MODELS, STATISTICAL; PSYCHOMOTOR PERFORMANCE; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SERIAL LEARNING; SPECIES SPECIFICITY;

EID: 64249133077     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004227     Document Type: Article

References (80)

1. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153: 321-330.
2. Green MF (2006) Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 67: e12.
3. Marder SR, Fenton W (2004) Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res 72: 5-9.
4. Mackworth NH (1950) Researches on the Measurement of Human Performance. London: His Majesty's Stationery Office.
5. Green DM, Swets JA (1966) Signal Detection Theory and Psychophysics. New York: Wiley & Sons.
6. McNicol D (1972) A primer of signal detection theory. London: George Allen & Unwin.
7. DuPaul GJ, Guevremont DC, Barkley RA (1992) Behavioral treatment of attention-deficit hyperactivity disorder in the classroom. The use of the attention training system. Behav Modif 16: 204-225.
8. Riccio CA, Reynolds CR, Lowe P, Moore JJ (2002) The continuous performance test: a window on the neural substrates for attention? Arch Clin Neuropsychol 17: 235-272.
9. Rosvold H, A M, Sarason I, Bransome ADJ, Beck LH (1956) A continuous performance test of brain damage. Journal of Consulting Psychology 20: 343-350.
10. Servan-Schreiber D, Cohen JD, Steingard S (1996) Schizophrenic deficits in the processing of context. A test of a theoretical model. Arch Gen Psychiatry 53: 1105-1112.
11. Conners CK (1985) The computerized continuous performance test. Psychopharmacol Bull 21: 891-892.
12. Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L (1988) The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res 26: 223-238.
13. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, et al. (2008) The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry 165: 203-213.
14. Chudasama Y, Robbins TW (2004) Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia. Psychopharmacology (Berl) 174: 86-98.
15. Cornblatt BA, Keilp JG (1994) Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull 20: 31-46.
16. Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12: 426-445.
17. Nuechterlein KH, Pashler HE, Subotnik KL (2006) Translating basic attentional paradigms to schizophrenia research: reconsidering the nature of the deficits. Dev Psychopathol 18: 831-851.
18. Markou A, Chiamulera C, Geyer MA, Tricklebank M, Steckler T (2008) Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models. Neuropsychopharmacology.
19. Floresco SB, Geyer MA, Gold LH, Grace AA (2005) Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia. Schizophr Bull 31: 888-894.
20. Hagan JJ, Jones DN (2005) Predicting drug efficacy for cognitive deficits in schizophrenia. Schizophr Bull 31: 830-853.
21. Sarter M (2006) Preclinical research into cognition enhancers. Trends Pharmacol Sci 27: 602-608.
22. Carter CS, Barch DM (2007) Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophr Bull 33: 1131-1137.
23. Sarter M (2004) Animal cognition: defining the issues. Neurosci Biobehav Rev 28: 645-650.
24. Carli M, Robbins TW, Evenden JL, Everitt BJ (1983) Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9: 361-380.
25. McGaughy J, Sarter M (1995) Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology (Berl) 117: 340-357.
26. Robbins TW (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163: 362-380.
27. Humby T, Laird FM, Davies W, Wilkinson LS (1999) Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. Eur J Neurosci 11: 2813-2823.
28. Day M, Balci F, Wan HI, Fox GB, Rutkowski JL, et al. (2008) Cognitive endpoints as disease biomarkers: optimizing the congruency of preclinical models to the clinic. Curr Opin Investig Drugs 9: 696-706.
29. Jones DN, Higgins GA (1995) Effect of scopolamine on visual attention in rats. Psychopharmacology (Berl) 120: 142-149.
30. Robbins TW (1998) Arousal and Attention: Psychopharmacological and Neuropsychophysical studies in experimental animals. In: Parasuraman R, ed. The Attentive Brain. Cambridge: MIT Press.
31. Sahakian BJ, Owen AM, Morant NJ, Eagger SA, Boddington S, et al. (1993) Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology (Berl) 110: 395-401.
32. Spratt C, Marston HM, Sharkey J, Kelly JS (2000) Comparison of rat and mouse attentional performance in the 5-choice serial reaction task. BNA 17: P49.03.
33. Caine SB, Negus SS, Mello NK (1999) Method for training operant responding and evaluating cocaine self-administration behavior in mutant mice. Psychopharmacology (Berl) 147: 22-24.
34. Martin LA, Goldowitz D, Mittleman G (2006) Sustained attention in the mouse: a study of the relationship with the cerebellum. Behav Neurosci 120: 477-481.
35. Greco B, Invernizzi RW, Carli M (2005) Phencyclidine-induced impairment in attention and response control depends on the background genotype of mice: reversal by the mGLU(2/3) receptor agonist LY379268. Psychopharmacology (Berl) 179: 68-76.
36. Patel S, Stolerman IP, Asherson P, Sluyter F (2006) Attentional performance of C57BL/6 and DBA/2 mice in the 5-choice serial reaction time task. Behav Brain Res 170: 197-203.
37. Baron SP, Meltzer LT (2001) Mouse strains differ under a simple schedule of operant learning. Behav Brain Res 118: 143-152.
38. Thinus-Blanc C, Save E, Rossi-Arnaud C, Tozzi A, Ammassari-Teule M (1996) The differences shown by C57BL/6 and DBA/2 inbred mice in detecting spatial novelty are subserved by a different hippocampal and parietal cortex interplay. Behav Brain Res 80: 33-40.
39. Ammassari-Teule M, Save E, de Marsanich B, Thinus-Blanc C (1998) Posterior parietal cortex lesions severely disrupt spatial learning in DBA mice characterized by a genetic hippocampal dysfunction. Behav Brain Res 95: 85-90.
40. Marston HM (1996) Analysis of cognitive function in animals, the value of SDT. Brain Res Cogn Brain Res 3: 269-277.
41. Parasuraman R (1998) The attentive brain. Cambridge: MIT Press.
42. See JE, Warm JS, Dember WN, Howe SR (1997) Vigilance and Signal Detection Theory: An Empirical Evaluation of Five Measures of Response Bias. The Journal of the Human Factos and Ergonomics Society 39: 14-29.
43. Grafton ST, Hazeltine E, Ivry RB (1998) Abstract and effector-specific representations of motor sequences identified with PET. J Neurosci 18: 9420-9428.
44. Maruff P, Pantelis C, Danckert J, Smith D, Currie J (1996) Deficits in the endogenous redirection of covert visual attention in chronic schizophrenia. Neuropsychologia 34: 1079-1084.
45. Cordova CA, Said BO, McCarley RW, Baxter MG, Chiba AA, et al. (2006) Sleep deprivation in rats produces attentional impairments on a 5-choice serial reaction time task. Sleep 29: 69-76.
46. Fletcher PJ, Tenn CC, Sinyard J, Rizos Z, Kapur S (2007) A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Neuropsychopharmacology 32: 1122-1132.
47. Inglis WL, Olmstead MC, Robbins TW (2001) Selective deficits in attentional performance on the 5-choice serial reaction time task following pedunculopontine tegmental nucleus lesions. Behav Brain Res 123: 117-131.
48. Risbrough V, Bontempi B, Menzaghi F (2002) Selective immunolesioning of the basal forebrain cholinergic neurons in rats: effect on attention using the 5-choice serial reaction time task. Psychopharmacology (Berl) 164: 71-81.
49. Young JW, Crawford N, Kelly JS, Kerr LE, Marston HM, et al. (2007) Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. Eur Neuropsychopharmacol 17: 145-155.
50. Young JW, Finlayson K, Spratt C, Marston HM, Crawford N, et al. (2004) Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor. Neuropsychopharmacology 29: 891-900.
51. Birkett P, Sigmundsson T, Sharma T, Toulopoulou T, Griffiths TD, et al. (2007) Reaction time and sustained attention in schizophrenia and its genetic predisposition. Schizophr Res 95: 76-85.
52. Egan MF, Goldberg TE, Gscheidle T, Weirich M, Bigelow LB, et al. (2000) Relative risk of attention deficits in siblings of patients with schizophrenia. Am J Psychiatry 157: 1309-1316.
53. Nestor PG, Faux SF, McCarley RW, Shenton ME, Sands SF (1990) Measurement of visual sustained attention in schizophrenia using signal detection analysis and a newly developed computerized CPT task. Schizophr Res 3: 329-332.
54. Stevens KE, Freedman R, Collins AC, Hall M, Leonard S, et al. (1996) Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology 15: 152-162.
55. Guan ZZ, Zhang X, Blennow K, Nordberg A (1999) Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport 10: 1779-1782.
56. D'Este L, Casini A, Puglisi-Allegra S, Cabib S, Renda TG (2007) Comparative immunohistochemical study of the dopaminergic systems in two inbred mouse strains (C57BL/6J and DBA/2J). J Chem Neuroanat 33: 67-74.
57. Robbins TW, Roberts AC (2007) Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cereb Cortex 17 Suppl 1: i151-160.
58. Hayward MD, Low MJ (2007) The contribution of endogenous opioids to food reward is dependent on sex and background strain. Neuroscience 144: 17-25.
59. Dudchenko P, Paul B, Sarter M (1992) Dissociation between the effects of benzodiazepine receptor agonists on behavioral vigilance and responsitivity. Psychopharmacology (Berl) 109: 203-211.
60. Steckler T, Keith AB, Wiley RG, Sahgal A (1995) Cholinergic lesions by 192 IgG-saporin and short-term recognition memory: role of the septohippocampal projection. Neuroscience 66: 101-114.
61. Warburton DM, Brown K (1972) The facilitation of discrimination performance by physostigmine sulphate. Psychopharmacologia 27: 275-284.
62. Frey PW, Colliver JA (1973) Sensitivity and responsibility measures for discrimination learning. Learning and Motivation 4: 327-342.
63. Chamberlain SR, Sahakian BJ (2007) The neuropsychiatry of impulsivity. Curr Opin Psychiatry 20: 255-261.
64. Evenden J (1999) Impulsivity: a discussion of clinical and experimental findings. J Psychopharmacol 13: 180-192.
65. Evenden JL (1999) Varieties of impulsivity. Psychopharmacology (Berl) 146: 348-361.
66. Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, et al. (2007) Similar Effects of the Selective Noradrenaline Reuptake Inhibitor Atomoxetine on Three Distinct Forms of Impulsivity in the Rat. Neuropsychopharmacology.
67. Rueckert L, Grafman J (1996) Sustained attention deficits in patients with right frontal lesions. Neuropsychologia 34: 953-963.
68. Salgado-Pineda P, Baeza I, Perez-Gomez M, Vendrell P, Junque C, et al. (2003) Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage 19: 365-375.
69. Muir JL, Everitt BJ, Robbins TW (1996) The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb Cortex 6: 470-481.
70. Broussard J, Sarter M, Givens B (2006) Neuronal correlates of signal detection in the posterior parietal cortex of rats performing a sustained attention task. Neuroscience 143: 407-417.
71. Bunge SA, Hazeltine E, Scanlon MD, Rosen AC, Gabrieli JD (2002) Dissociable contributions of prefrontal and parietal cortices to response selection. Neuro-image 17: 1562-1571.
72. Robinson DL, Bowman EM, Kertzman C (1995) Covert orienting of attention in macaques. II. Contributions of parietal cortex. J Neurophysiol 74: 698-712.
73. Klorman R, Brumaghim JT, Salzman LF, Strauss J, Borgstedt AD, et al. (1988) Effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features. J Abnorm Psychol 97: 413-422.
74. Strauss J, Lewis JL, Klorman R, Peloquin LJ, Perlmutter RA, et al. (1984) Effects of methylphenidate on young adults' performance and event-related potentials in a vigilance and a paired-associates learning test. Psychophysiology 21: 609-621.
75. Sostek AJ, Buchsbaum MS, Rapoport JL (1980) Effects of amphetamine on vigilance performance in normal and hyperactive children. J Abnorm Child Psychol 8: 491-500.
76. Weingartner H, Rapoport JL, Buchsbaum MS, Bunney WE Jr, Ebert MH, et al. (1980) Cognitive processes in normal and hyperactive children and their response to amphetamine treatment. J Abnorm Psychol 89: 25-37.
77. Levin ED, Conners CK, Silva D, Hinton SC, Meck WH, et al. (1998) Transdermal nicotine effects on attention. Psychopharmacology (Berl) 140: 135-141.
78. Riccio CA, Waldrop JJ, Reynolds CR, Lowe P (2001) Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 13: 326-335.
79. Sahgal A (1987) Some limitations of indices derived from signal detection theory: evaluation of an alternative index for measuring bias in memory tasks. Psychopharmacology (Berl) 91: 517-520.
80. Grier JB (1971) Nonparametric indexes for sensitivity and bias: computing formulas. Psychol Bull 75: 424-429.